Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 204 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$3.3B
Avg Funding
$130.6M
Cities
20

Export 204 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Alameda, United States
$36.0M
raised

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$212.0M
raised

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$4.0M
raised

Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.

Jul 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$132.0M
raised

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bethesda, United States
$7.0M
raised

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Del Mar, United States
$30.0M
raised

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$200.0M
raised

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Berkeley, United States
$125.0M
raised

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Englewood Cliffs, United States
$11.7M
raised

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$175.0M
raised

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$25.5M
raised

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$600.0M
raised

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$345.0M
raised

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newark, United States
$24.9M
raised

Rafael Holdings is a company focused on the development of novel cancer therapies.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Vancouver, Canada
$361K
raised

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$150.0M
raised

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wilmington, United States
$22.3M
raised

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$40.0M
raised

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$3.5M
raised

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$4.4M
raised

Medicenna is a clinical stage, privately held, immuno-oncology company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden
$3.0M
raised

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States
$200.0M
raised

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands
$59.2M
raised

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$805.0M
raised

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 204 companies

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

204 Therapeutics Post-IPO Equity Startups (September 2026) — Page 2 | VCBacked